InVera Medical announced FDA 510(k) clearance for the InVera infusion device for the minimally invasive treatment of diseased ...

Okami Medical announced the enrollment of the first patient in the ALPHA registry, a prospective, multicenter registry e ...

Route 92 Medical, Inc., a privately held medical technology company focused on neurovascular intervention, announced a $50 million ...

Endovascular Engineering, Inc. (E2), a commercial-stage medical technology company focused on the treatment of venous thromboembol ...

Endospan, an Israel-based developer of solutions for the endovascular repair of aortic arch disease, announced that the FDA ...

Baylis Medical Technologies Inc. announced FDA 510(k) clearance and the commercial launch of the company’s PowerWire 14 radi ...

Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which ...

HistoSonics announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial of the ...

Shape Memory Medical has announced the first patient enrollments in the FLAGSHIP study, a prospective single-arm open-la ...

Ellipsys Medical, Inc. announced that the Ellipsys vascular access system will re-enter the market, with commercial availabil ...

Concept Medical Inc. announced the presentation of primary results of the SirPAD randomized controlled trial of the company’ ...

Fluidx Medical Technology, Inc. announced that the first patient has been treated with the company’s Ultra embolic gel in a ...